Wednesday, February 10, 2010, 6:13am EST - Canadian Markets open in 3 hours and 17 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Gentium S.p.A (GENT)

 On Feb 9: 1.85 USD   0.00 (0.00%)  
MORE ON GENT
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Gentium SpA (NGM:GENT) Delayed quote dataEdit
Last Trade: 1.85 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 1.85
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 5.00
Day's Range: N/A - N/A
52wk Range: 0.28 - 4.00
Volume: 0
Avg Vol (3m): 32,649.2
Market Cap: 27.67M
P/E (ttm): N/A
EPS (ttm): N/A
Div & Yield: N/A (N/A%)
Gentium S.p.A (GENT)
1d  5d  3m  6m  1y  2y  5y 
 Add GENT to Portfolio   Download Data

HEADLINES
• Gentium Announces an Abstract for Defibrotide in the Prevention of Hepatic VOD has been Granted the Prestigious Van Bekkum Award by the EBMT
PRNewswire (Fri, Feb 5)
• Gentium Announces Extension of License and Supply and Cost Sharing Agreements with Sigma-Tau
Business Wire (Mon, Jan 11)
• Gentium Announces New Chairman of the Board
PRNewswire (Thu, Dec 17)
• Gentium Announces Final Clinical Trial Results for Defibrotide Presented at the American Society of Hematology Conference
Business Wire (Mon, Dec 7)
• Gentium Announces Resignation of Chairman of the Board
Business Wire (Mon, Dec 7)
• Gentium Reports Third Quarter Financial Results; Provides Financial Update
Business Wire (Mon, Nov 30)
• Gentium Announces Presentation of Defibrotide Clinical Data at the American Society of Hematology Annual Meeting
Business Wire (Mon, Nov 16)
• GENTIUM S.P.A. Financials
EDGAR Online Financials (Wed, Apr 8)
More Headlines for GENT...
ANALYST
EPS Est (next year) (Dec-08) : N/A
EPS Est (in 2 years) (Dec-09) : N/A
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Gentium S.p.A., a biopharmaceutical company, engages in the research, development, and manufacture of drugs to treat and prevent various vascular diseases and conditions related to cancer and cancer treatments.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices